Barely Significant
← all excerpts

Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE study.

J Neurol · 2025 · PMC11762429 · PMID 39862304

Europe PMCDOI
1
hedged sentence
0.0470
closest p · 0.9× alpha
0.0470
boldest claim

The sentences

only marginally significantp = 0.047actually significant
Moreover, the minimal reduction in HIT-6 score in responders at D2 was only marginally significant ( p = 0.047).

also in 5,085 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.